Cargando…
A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding
A rare germline duplication upstream of the bone morphogenetic protein antagonist GREM1 causes a Mendelian-dominant predisposition to colorectal cancer (CRC). The underlying disease mechanism is strong, ectopic GREM1 overexpression in the intestinal epithelium. Here, we confirm that a common GREM1 p...
Autores principales: | Lewis, Annabelle, Freeman-Mills, Luke, de la Calle-Mustienes, Elisa, Giráldez-Pérez, Rosa María, Davis, Hayley, Jaeger, Emma, Becker, Martin, Hubner, Nina C., Nguyen, Luan N., Zeron-Medina, Jorge, Bond, Gareth, Stunnenberg, Hendrik G., Carvajal, Jaime J., Gomez-Skarmeta, Jose Luis, Leedham, Simon, Tomlinson, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471812/ https://www.ncbi.nlm.nih.gov/pubmed/25131200 http://dx.doi.org/10.1016/j.celrep.2014.07.020 |
Ejemplares similares
-
Hereditary mixed polyposis syndrome is caused by a 40kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1
por: Jaeger, Emma, et al.
Publicado: (2012) -
Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside of the crypt base stem cell niche
por: Davis, Hayley, et al.
Publicado: (2014) -
TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population
por: Mitroi, Anca Florentina, et al.
Publicado: (2023) -
Association of TCF7L2, CASC8 and GREM1 Polymorphisms in Patients with Colorectal Cancer and Type II Diabetes Mellitus
por: Mitroi, Anca Florentina, et al.
Publicado: (2022) -
Bone Morphogenetic Protein Pathway Antagonism by
Grem1 Regulates Epithelial Cell Fate in Intestinal
Regeneration
por: Koppens, Martijn A. J., et al.
Publicado: (2021)